Louisiana Senate Bill SCR52

Louisiana 2010 Regular Session

• Introduced: 4/26/10
• Refer: 4/26/10
• Report Pass: 5/12/10
• Engrossed: 5/18/10
• Refer: 5/19/10
• Report Pass: 6/8/10
• Passed: 6/16/10

Caption

Directs the Department of Insurance to conduct study of the practices, procedures, and methods used by pharmacy benefit managers.

Impact

The implications of SCR52 could be significant in terms of influencing state laws governing pharmacy benefit managers and the healthcare industry at large. By initiating a formal study, the bill seeks to address potential issues related to the management of prescription drug benefits and to enhance oversight of PBMs. Depending on the findings, the Department of Insurance may propose specific legislation aimed at increasing transparency, accountability, and fair practices within the PBM industry. This may lead to more consumer protection measures related to prescription drug coverage.

Summary

SCR52 directs the Louisiana Department of Insurance to conduct a comprehensive study of the practices employed by pharmacy benefit managers (PBMs). This resolution stems from a growing concern about how PBMs administer prescription drug programs, affecting millions of citizens across the nation. The study aims to evaluate various practices of PBMs, such as their influence on prescribing decisions, the transparency of drug substitutions, and changes in patient cost-sharing obligations. The results of this investigation will be reported back to the state's Senate and House committees on insurance.

Sentiment

The sentiment surrounding SCR52 appears to reflect a growing awareness and concern regarding the healthcare marketplace, particularly the role that pharmacy benefit managers play within it. Stakeholders have shown support for the resolution, emphasizing the need for a thorough investigation into PBM operations to mitigate any potential negative repercussions for consumers. While there seems to be a consensus on conducting the study, opinions may diverge regarding the types of reforms or legislative changes that should follow, depending on the study's outcomes.

Contention

Notable points of contention may arise over how PBMs operate and their direct impact on patient care and costs. Stakeholders, including healthcare providers, insurance companies, and patient advocacy groups, may have varying views on the need for reform based on the findings of the Department of Insurance. If the study uncovers practices that are seen as detrimental to patient interests, it could generate calls for significant changes in how PBMs are regulated, adding to the ongoing debate regarding healthcare administration in Louisiana.